Graham Capital Management, L.P.

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 1315421 ROWAYTON, CT

Position in AVIR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$75,074

+$29,814 QoQ

Shares Held

16,145

+27.3% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 124 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. AVIR ranks #60 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	446,696	$25,376,799
2	INCY	Incyte Corp	15,632	$1,772,043
3	IONS	Ionis Pharmaceuticals Inc	16,717	$1,325,490
4	VKTX	Viking Therapeutics, Inc.	22,114	$862,667
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,256	$679,123
6	ARVN	Arvinas, Inc.	81,364	$676,134
7	PCVX	Vaxcyte, Inc.	11,107	$645,649
8	MRVI	Maravai Lifesciences Holdings, Inc.	92,277	$575,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$75,074	16,145	+27.3%	Shares	Sole	2026-08-14
2025-12-31	$45,260	12,678	-81.9%	Shares	Sole	2026-02-17
2025-09-30	$202,971	69,990	+181.9%	Shares	Sole	2025-11-14
2025-06-30	$89,366	24,824	+48.6%	Shares	Sole	2025-08-14
2025-03-31	$49,938	16,702	+33.5%	Shares	Sole	2025-05-15
2024-12-31	$41,911	12,511	+9.9%	Shares	Sole	2025-02-14
2023-12-31	$34,730	11,387	+12.6%	Shares	Sole	2024-02-14
2023-06-30	$37,822	10,113	-93.3%	Shares	Sole	2023-08-14
2022-09-30	$853,346	149,973	+594.6%	Shares	Sole	2022-11-14
2022-06-30	$153,296	21,591	-71.5%	Shares	Sole	2022-08-15
2022-03-31	$547,398	75,817	+126.9%	Shares	Sole	2022-05-16
2021-12-31	$298,783	33,421	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.